All Stories

  1. Prevalence and risk factors of gastro-oesophageal reflux disease in Saudi Arabia: a systematic review and meta-analysis
  2. Use of FibroScan-AST (FAST) Score and Fibrosis-4 Index to Identify Advanced Liver Fibrosis in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease
  3. Automated Fibrosis-4 Index: Simplifying Non-Alcoholic Fatty Liver Disease for Diabetologists
  4. Beyond genotype‐4: Direct‐acting antiviral agents in patients with chronic hepatitis C infection from the Eastern Province of Saudi Arabia
  5. Prediction of High-Risk Varices in Patients with Compensated Advanced Chronic Liver Disease in Saudi Arabia
  6. A global research priority agenda to advance public health responses to fatty liver disease
  7. Emergence of Post COVID-19 Vaccine Autoimmune Diseases: A Single Center Study
  8. Molecular and Genetic Characterization of Hepatitis B Virus (HBV) among Saudi Chronically HBV-Infected Individuals
  9. Genetic Subtypes and Natural Resistance Mutations in HCV Genotype 4 Infected Saudi Arabian Patients
  10. Genetic Subtypes and Natural Resistance Mutations in HCV Genotype 4 Infected Saudi Arabian Patients
  11. Clinical and Metabolic Characteristics of Non-Alcoholic Fatty Liver Disease Patients in Saudi Arabia: Data from the Systematic Observatory Liver Disease (SOLID) Registry
  12. Concomitant hepatic tuberculosis and hepatocellular carcinoma: a case report and review of the literature
  13. Entecavir versus other oral antiviral drugs for chronic hepatitis B
  14. Analysis of the Impact of Common Polymorphisms of the FTO and MC4R Genes with the Risk of Severe Obesity in Saudi Arabian Population
  15. Entecavir for chronic hepatitis B
  16. SASLT practice guidelines: Management of hepatitis C virus infection
  17. SASLT practice guidelines for the management of hepatitis C virus infection: Summary of recommendations
  18. Frequency of low bone mineral density in Saudi patients with inflammatory bowel disease
  19. Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies
  20. Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: The Hidden Epidemic
  21. Glypican-3-Expressing Hepatocellular Carcinoma in a Non-Cirrhotic Patient with Nonalcoholic Steatohepatitis: Case Report and Literature Review
  22. Rectal prolapse associated with extensive anorectal condyloma acuminata
  23. Reversal of liver fibrosis